MyFinsight
Home
Blog
About
Contact
Download
Download image
Notes payable, net
$4,300K
Proceeds from issuance of
common stock, net of...
$354K
Net cash provided by
financing activities
$4,654K
Net increase
(decrease) in cash and cash...
$1,230K
Canceled cashflow
$3,424K
Accounts payable
$2,288K
Net amortization of
discount on notes payable
$623K
Accrued expenses and
other current...
$247K
Stock-based compensation
expense
$156K
Prepaid expenses and
other current assets
-$103K
Net cash used in
operating activities
-$3,424K
Canceled cashflow
$3,417K
Net loss
-$5,838K
Other assets
$1,003K
Research and development
expenses
$3,073K
General and
administrative expenses
$2,157K
Other (expense)
income, net
-$608K
Back
Back
Cash Flow
Rein Therapeutics, Inc. (RNTX)
Rein Therapeutics, Inc. (RNTX)
source: myfinsight.com